2023

  1. ME/CFS Skeptic

    2023: looking back on a year of ME/CFS research

    We've written a review of the most interesting ME/CFS studies of 2023. Would be interesting to hear if we missed any important studies that should have been included. https://mecfsskeptic.com/2023-looking-back-on-a-year-of-me-cfs-research/ This was quite a lot of material to process so there...
  2. Wyva

    Preprint Infection-induced vascular inflammation in COVID-19 links focal microglial dysfunction with neuropathologies through (...), 2023, Fekete et al

    Full title: Infection-induced vascular inflammation in COVID-19 links focal microglial dysfunction with neuropathologies through IL-1/IL-6-related systemic inflammatory states Abstract COVID-19 is associated with diverse neurological abnormalities, which predict poor outcome in patients...
  3. Wyva

    CDC Data Brief: Myalgic Encephalomyelitis/Chronic Fatigue Syndrome in Adults: United States, 2021–2022, 2023, Vahratian, Unger et al

    Key findings Data from the National Health Interview Survey In 2021–2022, 1.3% of adults had myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS). The percentage of adults who had ME/CFS increased with age through ages 60–69 and then declined among those age 70 and older. White...
  4. Wyva

    Psychometric validation of the French Multidimensional Chronic Asthenia Scale (MCAS) in a sample of 621 pts with chronic fatigue, 2023, Banovic et al

    Psychometric validation of the French Multidimensional Chronic Asthenia Scale (MCAS) in a sample of 621 patients with chronic fatigue Abstract Background Psychometric validation of the Multidimensional Chronic Asthenia Scale (MCAS) was conducted in order to provide an effective tool for...
  5. Wyva

    Review Diagnosis and Management of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome, 2023, Grach et al

    Abstract Myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) is a chronic neurologic disease often preceded by infection. There has been increased interest in ME/CFS recently because of its significant overlap with the post-COVID syndrome (long COVID or post-acute sequelae of COVID)...
  6. Wyva

    Trial Report Effects of six-month creatine supplementation on patient- and clinician-reported outcomes, and tissue creatine levels (...), 2023, Slankamenac et al

    Full title: Effects of six-month creatine supplementation on patient- and clinician-reported outcomes, and tissue creatine levels in patients with post-COVID-19 fatigue syndrome Abstract Dietary creatine has been recently put forward as a possible intervention strategy to reduce post-COVID-19...
  7. Wyva

    Stellate Ganglion Block Relieves Long COVID-19 Symptoms in 86% of Patients: A Retrospective Cohort Study, 2023, Pearson et al

    Abstract Post-COVID-19 condition, also known as long COVID-19 syndrome and post-acute sequelae of SARS-CoV-2, encompasses an array of symptoms that persist well beyond the initial phase of the viral infection. These symptoms can range in intensity, from mild and manageable to severe and...
  8. Wyva

    Gray Matter Changes Following Mild COVID-19: An MR Morphometric Study in Healthy Young People, 2023, Janszky et al

    Abstract Background Although COVID-19 is primarily an acute respiratory infection, 5%–40% of patients develop late and prolonged symptoms with frequent neurological complaints, known as long COVID syndrome. The presentation of the disease suggests that COVID infection may cause functional...
  9. Wyva

    Review Post-COVID Conditions, 2023, Mueller et al

    Abstract Postinfectious syndromes have been described since the Spanish influenza pandemic of 1918. A similar syndrome—post-COVID condition (PCC)—is common; it occurs months after COVID-19 infection and involves fatigue, postexertional malaise, dyspnea, memory loss, diffuse pain, and...
  10. E

    Prolonged indoleamine 2,3-dioxygenase-2 activity and associated cellular stress in post-acute sequelae of SARS-CoV-2 infection, 2023, Guo et al

    Prolonged indoleamine 2,3-dioxygenase-2 activity and associated cellular stress in post-acute sequelae of SARS-CoV-2 infection Background Post-acute sequela of SARS-CoV-2 infection (PASC) encompass fatigue, post-exertional malaise and cognitive problems. The abundant expression of the...
  11. Wyva

    Review Multisystem inflammatory syndrome in children (MIS-C): Implications for long COVID, 2023, Constantin et al

    Abstract The COVID-19 pandemic caused by the coronavirus 2 of the severe acute respiratory syndrome (SARS-CoV-2) has significantly affected people around the world, leading to substantial morbidity and mortality. Although the pandemic has affected people of all ages, there is increasing...
  12. T

    Severe ME Day, August 8 2023 and Severe ME week

    A thread on this
  13. Wyva

    Long COVID and possible preventive options, 2023, Sebők, Gyires

    Abstract Most of the people who suffered from COVID-19 fully recovered, but approximately 10–20% of them developed a wide variety of symptoms after they recover from their initial illness. Long COVID can develop at any patient; however, several studies suggest that the development of Long Covid...
  14. Wyva

    Cognitive functioning in POTS among different body positions: a prospective pilot study (POTSKog study), 2023, Maier et al

    Full title: Cognitive functioning in postural orthostatic tachycardia syndrome among different body positions: a prospective pilot study (POTSKog study) Abstract Purpose Approximately 96% of patients with postural orthostatic tachycardia syndrome (PoTS) report cognitive complaints. We...
  15. Wyva

    Alcohol intolerance and myalgic encephalomyelitis/chronic fatigue syndrome, 2023, Maciuch, Jason

    Abstract BACKGROUND The literature is mixed about the occurrence of alcohol intolerance among patients with myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS). Surveys that asked respondents with ME/CFS whether they experienced alcohol intolerance within a recent time frame might...
  16. Wyva

    Review Biomarkers for myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS): a systematic review, 2023, Maksoud et al

    Abstract Background Myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) is a multifaceted condition that affects most body systems. There is currently no known diagnostic biomarker; instead, diagnosis is dependent on application of symptom-based case criteria following exclusion of any...
  17. Wyva

    Clinical improvement of Long-COVID is associated with reduction in autoantibodies, lipids, and inflammation following (...), 2023, Achleitner et al

    Full title: Clinical improvement of Long-COVID is associated with reduction in autoantibodies, lipids, and inflammation following therapeutic apheresis Abstract In the aftermath of the COVID-19 pandemic, we are witnessing an unprecedented wave of post-infectious complications. Most...
  18. Wyva

    Review article: What is really ‘Long COVID’?, 2023, Szabo et al

    Abstract The previous acute respiratory diseases caused by viruses originating from China or the middle east (e.g., SARS, MERS) remained fast developing short diseases without major sequalae or any long-lasting complications. The new COVID-19, on the other hand, not only that it rapidly spread...
  19. Wyva

    American Academy of Neurology - Annual Meeting April 22-27 2023

    Here is the link to the event on the website of the AAN. And here you can check out the abstracts of the topics that are going to be presented. I typed in ME/CFS keywords but couldn't find anything, however, the word covid brings up plenty of abstracts. I haven't really gone through all of...
  20. Sly Saint

    BABCP 2023 Cardiff (British Association for Behavioural & Cognitive Psychotherapies)

    pre conference workshop: https://babcp2023.org/pre-conference-workshops
Back
Top Bottom